Premarket Biotech Digest: Understanding Multiple Sclerosis, Gilead's Hep C Sales, AstraZeneca Halts Trial
October 12 2015 - 9:51AM
Seeking Alpha
http://seekingalpha.com/article/3565686-premarket-biotech-digest-understanding-multiple-sclerosis-gileads-hep-c-sales-astrazeneca-halts-trial?source=partner_advfn&utm_source=advfn&utm_medium=cpc&utm_campaign=investorshub
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Mar 2024 to Apr 2024
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Apr 2023 to Apr 2024